| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 Record Registrations for BioTrinity 2009 (April 2-3) UK's Premier Biotechnology and Investment Conference Registrations for BioTrinity 2009 have surged in recent weeks, and we're delighted to announce record registration levels 50% higher than last year. With four weeks to go, the UK's premier biotech and investment conference boasts the participation of thirty VCs and investors with over $33bn under management among more than 230 companies confirmed as participating. 60% of the top 20 global pharma now have senior licensing presence confirmed including AstraZeneca, Roche, Novartis, Lilly and GSK. Five key facts about BioTrinity 2009 - Oxford
For the first time, BioTrinity 2009 will be opened by Lord Davies of Abersoch CBE, the Minister of State for Trade and Investment at DBERR and the FCO, who will be discussing how the UK government will be fighting the economic challenges facing our industry. Also for the first time, BioTrinity 2009 will also feature plenaries and panel discussions involving some of Oxford's most successful entrepreneurs Ian Nicholson, Bryan Morton, Anker Lundemose and Bruce Savage, as well as the entrpreneurs John Burt, David Knowles and Ken Powell drawn from across the UK who have returned nearly $500m of value to their investors. Delegates from 14 countries will be present, and 35 corporate presentations will be heard from companies selected from Oxford, London, Cambridge as well as Bristol, Southampton, Kent, Nottingham, Manchester and Newcastle, making BioTrinity a UK Biotechnology Showcase. The latest addition is Heptares Therapeutics, which just completed a £21m funding round. In yet another first, BioTrinity 2009 will feature live recording of interviews by PharmaTV adjacent to the main networking hub, so if you want to appear on the groundbreaking online TV channel for the biopharma industry, make sure you are in Oxford from April 2-3, 2009. BioTrinity unites the UK’s biotech industry, and provides an ideal platform to meet with pharma, investors and biotech companies in the most beautiful city in England, just 1 hours' drive from Heathrow International Airport. The updated programme for BioTrinity has been published online and can be downloaded. ........................................................................................... Is your company missing from the list of companies attending BioTrinity 2009?
........................................................................................... What other people think:"My first time at a UK partnering conference was
BioTrinity 2008, and I did a deal with an NZ pharma as a direct
result". Allen Hakimi, Managing Director at Technomark
Life Sciences "As a direct result of our focused partnering meetings we introduced proteros to potential clients at BioTrinity 2008 which we are pleased to report resulted in several new opportunities and one of which has developed into a substantial business relationship". Gordon J Woodrow, VP at Proteros biostructures GmbH "...I would like to congratulate you on an excellent
meeting.." "...Congratulations on such a good event. I had a very productive day with lots of organized and impromptu meetings - a very worthwhile event for me." Dr Charles Potter, CEO, Glide Pharma
Register online now at www.biotrinity.com ............................................................................................ Thanks to our Sponsors:
............................................................................................ BioTrinity is organised by OBN - Rapidly becoming the UK's leading biotech network
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
© 2006-2009 OBN |
12 of
world's top 20 global pharma represented
